Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Transp Health. 2016 Sep 13;3(4):426–439. doi: 10.1016/j.jth.2016.08.006

Table 2.

Descriptive statistics by change in walkability between baseline (2000-2001) and follow-up (2005-2006) exams, n=1,079 middle-aged adults who moved residential locations between exams

Groups by change in walkability index
Characteristics All participants (n=1,079) Decrease (n=394)a Minimal change (n=510)b Increase (n=175)c p
Built environment variables
Walkability index at baseline 20.14 (7.70) 23.24 (7.14) 19.14 (6.95) 16.07 (8.37) 0.00***
Change in walkability index −2.09 (7.04) −8.99 (4.87) −0.19 (1.75) 7.91 (5.09)
Moved for built environment (%) 58.85 54.06 62.35 59.43 0.04**
Health outcomes at baseline
Physical activity from walking
    Participation (%) 75.72 76.65 73.33 80.57 0.14
    Exercise units 49.31 (50.59) 49.26 (50.48) 49.44 (51.88) 49.05 (47.18) 0.99
Body mass index, kg/m2 28.41 (6.50) 28.12 (6.41) 28.34 (6.47) 29.27 (6.78) 0.14
Waist circumference, cm 88.79 (15.01) 88.44 (14.63) 88.51 (15.40) 90.43 (14.68) 0.29
Systolic blood pressure, mmHg 112.24 (13.69) 111.00 (12.81) 112.92 (14.22) 113.07 (13.78) 0.08*
HOMA-IR (insulin resistance) d 2.21 (1.66) 2.14 (1.42) 2.25 (1.86) 2.22 (1.51) 0.60
Triglycerides, mg/dL 95.37 (57.22) 95.81 (58.71) 93.93 (56.49) 98.57 (56.08) 0.64
LDL cholesterol, mg/dL 113.44 (33.90) 113.17 (33.08) 112.76 (35.39) 116.03 (31.24) 0.53
HDL cholesterol, mg/dL 51.29 (14.49) 51.18 (14.46) 51.43 (14.63) 51.15 (14.23) 0.96
C-reactive protein, ug/mL 3.11 (5.06) 2.77 (3.91) 3.35 (6.00) 3.16 (4.27) 0.23
Atherogenic dyslipidemia (%) 9.27 10.15 8.43 9.71 0.66
Change in health outcomes
Change in walking participation 0.32
    Started participating (%) 10.84 11.17 11.96 6.86
    Stopped participating (%) 15.48 16.75 14.90 14.29
Change in walking exercise units −0.37 (56.60) −3.72 (55.38) 2.07 (57.96) 0.02 (55.20) 0.31
Change in body mass index, kg/m2 0.78 (2.83) 0.90 (2.49) 0.72 (2.81) 0.66 (3.54) 0.54
Change in waist circumference, cm 2.68 (8.28) 2.91 (8.49) 2.50 (8.14) 2.71 (8.22) 0.76
Change in systolic blood pressure, mmHg 4.02 (13.07) 4.95 (12.47) 3.77 (14.00) 2.62 (11.37) 0.12
Change in HOMA-IR d 0.23 (1.57) 0.32 (1.51) 0.18 (1.67) 0.13 (1.40) 0.31
Change in triglycerides, mg/dL 6.02 (50.30) 8.93 (53.21) 4.21 (49.49) 4.74 (45.65) 0.35
Change in LDL cholesterol, mg/dL −2.88 (26.82) −0.16 (24.30) −6.13 (29.09) 0.44 (24.23) 0.00***
Change in HDL cholesterol, mg/dL 3.42 (10.20) 3.18 (10.02) 3.73 (10.59) 3.08 (9.43) 0.64
Change in C-reactive protein, ug/mL −0.37 (5.09) −0.30 (3.14) −0.73 (5.16) 0.52 (7.70) 0.02**
Change in atherogenic dyslipidemia 0.58
    New case (%) 5.38 5.33 4.90 6.86
    Removed case (%) 5.00 6.09 4.12 5.14
Covariates at baseline
Age, in years 39.67 (3.68) 39.74 (3.66) 39.64 (3.71) 39.55 (3.66) 0.84
Female (%) 54.77 53.81 55.69 54.29 0.85
Race/ethnicity 0.41
    Black, not Hispanic (%) 50.88 48.48 52.94 50.29
    White, not Hispanic (%) 49.12 51.52 47.06 49.71
More than high school (vs. less/equal) (%) 58.20 58.12 59.02 56.00 0.78
Income, in thousands 62.51 (38.86) 62.67 (37.84) 63.02 (39.45) 60.63 (39.58) 0.78
Household size 3.04 (1.61) 2.96 (1.47) 3.15 (1.71) 2.89 (1.60) 0.08*
Currently married (%) 46.80 46.70 48.82 41.14 0.21
Currently working (%) 85.82 86.55 86.27 82.86 0.47
Current smoker (%) 23.63 23.86 23.73 22.86 0.97
Health problems (%) 14.55 12.94 15.10 16.57 0.47
On medication(s) for hypertension (%) 6.58 5.33 7.45 6.86 0.44
On medication(s) for cholesterol (%) 1.11 1.02 0.98 1.71 0.71
Change in covariates, as applicable
Change in income 5.82 (28.54) 8.06 (26.19) 6.42 (28.46) −0.99 (32.66) 0.00***
Change in household size −0.18 (1.46) −0.10 (1.35) −0.20 (1.53) −0.28 (1.50) 0.33
Change in marital status 0.01**
    New marriage (%) 10.75 12.94 10.59 6.29
    No longer married (%) 8.90 6.85 8.63 14.29
Change in employment status 0.70
    Started working (%) 6.12 6.09 5.49 8.00
    Stopped working (%) 11.49 12.44 11.37 9.71
Change in smoking status 0.06*
    Started smoking (%) 2.59 1.52 2.35 5.71
    Stopped smoking (%) 4.82 4.82 5.49 2.86
Change in health problems 0.87
    New problems (%) 9.55 10.41 8.82 9.71
    No longer problems (%) 9.27 8.38 9.61 10.29
Change in medication use
    Started hypertension meds. (%) 9.09 8.40 9.02 10.86 0.35
    Started cholesterol meds. (%) 6.58 6.35 8.04 2.86 0.11

LDL = low-density lipoprotein, HDL = high-density lipoprotein, HOMA-IR = homeostasis model assessment of insulin resistance

*

significant at 90% confidence

**

significant at 95% confidence

***

significant at 99% confidence

Groups are based on change in walkability, with cut points set at ± 0.5 SD of the change variable (+3.52 and −3.52)

a

Decrease: change in walkability ranges from −35.95 to −3.53

b

Minimal change in walkability ranges from −3.50 to 3.51

c

Increase: change in walkability ranges from 3.58 to 40.88

d

Participants with diabetes at baseline (n=42) excluded from HOMA-IR calculation